Page 117 - HIVMED_v21_i1.indb

Page 26 of 34 Guideline

54. UNODC, WHO, UNAIDS. WHO, UNODC, UNAIDS Technical Guide for countries to 79. Harris M, Rhodes T. Methadone diversion as a protective strategy: The harm
set targets for universal access to HIV prevention, treatment and care fro injecting reduction potential of ‘generous constraints’. Int J Drug Policy. 2013;24(6):e43–e50.
drug users – 2012 Revision. Vienna: United Nations Office on Drugs and Crime; https://doi.org/10.1016/j.drugpo.2012.10.003
2012. 80. Eurpean Monitoring Centre for Drugs and Drug Addiction. Strategies to prevent
55. Kwon JA, Anderson J, Kerr CC, et al. Estimating the cost-effectiveness of needle- diversion of opioid substitution treatment medications. LIsbon: Eurpean
syringe programs in Australia. AIDS. 2012;26(17):2201–2210. https://doi.org/ Monitoring Centre for Drugs and Drug Addiction, 2016; p. 9.
10.1097/QAD.0b013e3283578b5d 81. Weich L, Nowbath H, Flegar S, et al. South African guidelines for the management
56. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programmes. Int of opioid dependence. Updated 2013. Pretoria: South African Addiction Medicine
J Drug Policy. 2005 Dec;16(January):31–44. https://doi.org/10.1016/j.drugpo. Society; 2013.
2005.02.004 82. Alford DP, Compton P, Samet JH. Acute pain management for patients receiving
57. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention maintenance methadone or buprenorphine therapy. Ann Intern Med.
of HIV infection for people who inject drugs: Why individual, structural, and 2006;144(2):127–134. https://doi.org/10.7326/0003-4819-144-2-200601170-
combination approaches are needed. Lancet [serial online]. 2010 Jul 24 [cited 00010
2012 Mar 14];376(9737):285–301. Available from: http://www.ncbi.nlm.nih.gov/ 83. United Nations Office on Drugs and Crime, World Health Organization. Opioid
pubmed/20650522 overdose: Preventing and reducing opioid overdose mortality. Discussion paper.
58. Hunt N, Ashton M, Lenton S, Mitcheson L, Nelles B. A review of the evidence-base New York, NY: United Nations; 2013.
for harm reduction approaches to drug use. 2020 Oct 8. Available from: https:// 84. WHO. Community management of opioid overdose. Geneva: World Health
www.hri.global/files/2010/05/31/HIVTop50Documents11.pdf Organization, 2014; p. 374–395.
59. World Health Organization. Effectiveness of sterile needle and syringe 85. WHO, MHGAP. mhGAP intervention guide for mental, neurological and substance
programming in reducing HIV/AIDS among injecting drug users. Geneva: World use disorders in non-specialized health settings. Version 2.0. Geneva: World
Health Organization; 2004. Health Organization; 2016.
60. World Health Organization. Global hepatitis report, 2017 [homepage on the 86. Ford C. Guidance for working with cocaine and crack users in primary care
Internet]. Geneva: World Health Organization, 2017; p. 62. Available from: http:// [homepage on the Internet]. London: Royal College of General Practitioners,
www.who.int/hepatitis 2004; p. 39. Available from: www.smmgp.co.uk
61. Beletsky L, Agrawal A, Moreau B, Kumar J, Weiss-Laxer N, Heimer R. Can Police 87. Petry NM, Stitzer ML. Contingency management: Using motivational incentives
training help align law enforcement and HIV prevention ? Preliminary evidence to improve drug abuse treatment. Yale Univ Psychother Dev Cent Train Ser.
from the field. Am J Public Health. 2011;101(11):2012–2015. https://doi. 2002;(6):1–55.
org/10.2105/AJPH.2011.300254
88. Department of Health. Standard treatment guidelines and essential medicines list
62. Cepeda JA, Beletsky L, Sawyer A, et al. Occupational safety in the age of the opioid for South Africa. Hospital level. Adults. Third. Pretoria: National Department of
crisis: Needle stick injury among Baltimore Police. J Urban Heal. 2017;94(March Health; 2015.
2012):100–103. https://doi.org/10.1007/s11524-016-0115-0 89. DeBeck K, Wood E, Zhang R, Tyndall M, Montaner J, Kerr T. Police and public
63. Davis CS, Johnston J, Zerden LDS, Clark K, Castillo T, Childs R. Attitudes of North health partnerships: Evidence from the evaluation of Vancouver’s supervised
Carolina law enforcement officers toward syringe decriminalization. Drug injection facility. Subst Abuse Treat Prev Policy [serial online]. 2008;3(1):11.
Alcohol Depend. 2014;1(144):265–269. https://doi.org/10.1016/j.drugalcdep. Available from: http://www.doaj.org/doaj?func=abstract&id=259996
2014.08.007 90. Belackova V, Salmon A. Overview of International Literature. Supervised injecting
64. Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe facilitiesa nd drug consumption rooms. Sydney: United Medically Supervised
Programmes in people who inject drugs – An overview of systematic reviews. BMC Injecting Centre; 2017.
Public Health. 2017;17(1):1–15. https://doi.org/10.1186/s12889-017-4210-2 91. Rigoni R, Breeksema J, Woods S. Speed limits: Harm reduction for people who use
65. De Montigny L, Vernez Moudon A, Leigh B, Young K. Assessing a drop box stimulants [homepage on the Internet]. Amsterdam: Mainline, 2018; p. 144.
programme: A spatial analysis of discarded needles. Int J Drug Policy [serial Available from: http://fileserver.idpc.net/library/Mainline_REPORT_complete.pdf
online]. 2010 May;21(3):208–214. Available from: https://linkinghub.elsevier. 92. Harm reduction coalition. Fentanyl [homepage on the Internet]. Fentanyl test
com/retrieve/pii/S0955395909001108 stips. [cited 2019 Oct 22]. Available from: https://harmreduction.org/issues/
66. Klein SJ, Candelas AR, Cooper JG, et al. Increasing safe syringe collection fentanyl/
sites in New York State. Public Health Rep [serial online]. 2008 Jul;123(4): 93. Frasca T, Ibitoye M, Dolezal C, Carballo A, Studies B. testing increases if other STIs
433–440. Available from: http://journals.sagepub.com/doi/10.1177/0033354 can be detected. 2018;21(2):501–504.
90812300404
67. Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to 94. Nguyen VTT, Phan HTT, Kato M, et al. Community-led HIV testing services including
HIV self-testing and assisted partner notification services in Vietnam: Lessons
sterile syringes through San Francisco pharmacies and the association with HIV from a pilot study in a concentrated epidemic setting. J Int AIDS Soc.
risk behavior among injection drug users. J Urban Heal [serial online]. 2010 Jul 2019;22(S3):40–48. https://doi.org/10.1002/jia2.25301
5;87(4):534–542. Available from: http://link.springer.com/10.1007/s11524-010-
9468-y 95. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with
HIV infection: A review of barriers and ways forward. Lancet [serial online]. 2010
68. Tookes HE, Kral AH, Wenger LD, et al. A comparison of syringe disposal practices Jul;376(9738):355–366. Available from: https://linkinghub.elsevier.com/retrieve/
among injection drug users in a city with versus a city without needle and syringe pii/S014067361060832X
programs. Drug Alcohol Depend [serial online]. 2012 Jun;123(1–3):255–259.
Available from: https://linkinghub.elsevier.com/retrieve/pii/S0376871611 96. Tahseen S, Shahnawaz H, Riaz U, et al. Systematic case finding for tuberculosis in
005229 HIV-infected people who inject drugs: Experience from Pakistan. Int J Tuberc Lung
Dis. 2018;22(2):187–193. https://doi.org/10.5588/ijtld.17.0390
69. Aitken C, Moore D, Higgs P, Kelsall J, Kerger M. The impact of a police crackdown
on a street drug scene: Evidence from the street. Int J Drug Policy. 2002;13: 97. Gupta A, Mbwambo J, Mteza I, et al. Active case finding for tuberculosis among
189–198. https://doi.org/10.1016/S0955-3959(02)00075-0 people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. Int
J Tuberc Lung Dis [serial online]. 2014 Jul 1;18(7):793–798. Available from: http://
70. Luisa Mittal M, Beletsky L, Patiño E, et al. Prevalence and correlates of needle- openurl.ingenta.com/content/xref?genre=article&issn=1027-3719&volume=18&
stick injuries among active duty police officers in Tijuana, Mexico. J Int AIDS Soc issue=7&spage=793
[serial online]. 2016;19(4 (Suppl 3)):1–7. Available from: http://www.jiasociety. 98. World Health Organization. Integrating collaborative TB and HIV services within a
org/index.php/jias/article/view/20874 comprehensive package of care for people who inject drugs: Consolidated
71. Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting guidelines [homepage on the Internet]. Geneva: World Health Organization; 2016.
drug users: the past, present, and future. Lancet [serial online]. 2010 Jul 24 [cited Available from: www.who.int/about/licensing/copyright_form/en/index.html
2012 Mar 9];376(9737):268–284. Available from: http://www.ncbi.nlm.nih.gov/ 99. World Health Organization (WHO). Guidelines for the care and treatment of
pubmed/20650523 persons diagnosed with chronic hepatitis c virus infection. Geneva: World Health
72. Latypov A, Bidordinova A, Khachatrian A. Opioid substitution therapy in Eurasia: Organization; 2018.
How to increase the access and improve the quality. IDPC Briefing Paper. London: 100. RAND Health. Mental health and substance abuse issues among people with
International Drug Policy Consortium, 2012; p. 1–19. HIV. Lessons from HCSUS. Santa Monica, CA: RAND corporation; 2007.
73. WHO. WHO guidance on the prevention of viral hepatitis B and C among people 101. Kader R, Govender R, Seedat S, Koch JR, Parry C. Understanding the impact of
who inject drugs. Geneva: World Health Organization; 2012. hazardous and harmful use of alcohol and/or other drugs on ARV adherence and
74. WHO. Guidelines for the psychosocially assisted pharmacological treatment of disease progression. PLoS One. 2015;10(5):1–12. https://doi.org/10.1371/
journal.pone.0125088
opioid dependence. Geneva: World Health Organization; 2009.
102. South African Government. Mental Health Care Act No 17 of 2002 [homepage
75. Bruneau J, Ahamad K, Goyer MÈ, et al. Management of opioid use disorders: A on the Internet]. Volume 469. Government Gazette. Cape Town: South African
national clinical practice guideline. CMAJ. 2018;190(9):E247–E257. https://doi. Government; 2002. Available from: http://www.nsw.gov.au/sites/default/files/
org/10.1503/cmaj.170958 Government_Gazette_2_December.pdf#page=15
76. American Psychiatric Association. Diagnostic and statistical manual of mental 103. Maher L, Dixon TC. Collateral damage and the criminalisation of drug use. Lancet
disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013. HIV [serial online]. 2017 Aug;4(8):e326–e327. Available from: https://
77. Rothstein MA. Drug testing in the workplace: The challenge to employment linkinghub.elsevier.com/retrieve/pii/S2352301817300711
relations and employment law. Chic Kent Law Rev. 1987;63(3):684–743. 104. Jelsma M. UN Common Position on drug policy – Consolidating system-wide
78. Oosthuizen NM, Laurens JB. Efavirenz interference in urine screening coherence. London: International Drug Policy Consortium, 2019; p. 1–36.
immunoassays for tetrahydrocannabinol. Ann Clin Biochem An Int J Biochem Lab 105. Drug Policy Alliance. Drug decriminalization in portugal learning from a health
Med [serial online]. 2012 Mar 1;49(2):194–196. Available from: http://acb. and human-centered approach [homepage on the Internet]. New York, NY: Drug
sagepub.com/lookup/doi/10.1258/acb.2011.011118 Policy Alliance; 2018. Available from: www.drugpolicy.org3
http://www.sajhivmed.org.za 109 Open Access